BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36606610)

  • 41. Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesis.
    Renosi F; Roggy A; Giguelay A; Soret L; Viailly PJ; Cheok M; Biichle S; Angelot-Delettre F; Asnafi V; Macintyre E; Geffroy S; Callanan M; Petrella T; Deconinck E; Daguindau E; Harrivel V; Bouyer S; Salaun V; Saussoy P; Feuillard J; Fuseau P; Saas P; Adotévi O; Jardin F; Ferrand C; Preudhomme C; Colinge J; Roumier C; Garnache-Ottou F
    Blood Adv; 2021 Mar; 5(5):1540-1551. PubMed ID: 33687433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
    Wilson NR; Bover L; Konopleva M; Han L; Neelapu S; Pemmaraju N
    Leuk Lymphoma; 2022 Jan; 63(1):19-30. PubMed ID: 34486917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumor-forming plasmacytoid dendritic cells in acute myelocytic leukemia: a report of three cases and literature review.
    Wang P; Feng Y; Deng X; Liu S; Qiang X; Gou Y; Li J; Yang W; Peng X; Zhang X
    Int J Clin Exp Pathol; 2017; 10(7):7285-7291. PubMed ID: 31966568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
    Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spontaneous regression of cutaneous blastic plasmacytoid dendritic cell neoplasm followed by acute monocytic leukemia evolving from myelodysplastic syndrome.
    Yasuda H; Takaku T; Tomomatsu J; Hosone M; Tanaka H; Komatsu N
    Intern Med; 2014; 53(23):2717-20. PubMed ID: 25447656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-Cell Multiomics Reveals Clonal T-Cell Expansions and Exhaustion in Blastic Plasmacytoid Dendritic Cell Neoplasm.
    DePasquale EAK; Ssozi D; Ainciburu M; Good J; Noel J; Villanueva MA; Couturier CP; Shalek AK; Aranki SF; Mallidi HR; Griffin GK; Lane AA; van Galen P
    Front Immunol; 2022; 13():809414. PubMed ID: 35359938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone marrow clonal hematopoiesis is highly prevalent in blastic plasmacytoid dendritic cell neoplasm and frequently sharing a clonal origin in elderly patients.
    Khanlari M; Yin CC; Takahashi K; Lachowiez C; Tang G; Loghavi S; Bah I; Wang W; Konoplev S; Medeiros LJ; Pemmaraju N; Khoury JD; Wang SA
    Leukemia; 2022 May; 36(5):1343-1350. PubMed ID: 35279700
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blastic Plasmacytoid Dendritic Cell Neoplasm: Progress in Cell Origin, Molecular Biology, Diagnostic Criteria and Therapeutic Approaches.
    Cheng W; Yu TT; Tang AP; He Young K; Yu L
    Curr Med Sci; 2021 Jun; 41(3):405-419. PubMed ID: 34218354
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunohistochemical evaluation of BCL-2 expression in acute myeloid leukemia, myeloid sarcoma, and blastic plasmacytoid dendritic cell neoplasm].
    Saika W; Kawahara M; Tashiro H; Teramoto Y; Nagai S; Kumode M; Iwasa M; Asai A; Fujishiro A; Nishimura R; Minamiguchi H; Moritani S; Kito K; Andoh A
    Rinsho Ketsueki; 2020; 61(12):1647-1653. PubMed ID: 33441515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?
    Petrella T; Facchetti F
    Autoimmunity; 2010 Apr; 43(3):210-4. PubMed ID: 20166873
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
    Paluri R; Nabell L; Borak S; Peker D
    Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients.
    Guolo F; Minetto P; Clavio M; Marcolin R; Miglino M; Passannante M; Caviglia F; Ballerini F; Tedone E; Kunkl A; Mangerini R; Contini P; Colombo N; Cagnetta A; Cea M; Carminati E; Pugliese G; Gobbi M; Lemoli RM
    Leuk Lymphoma; 2020 Jul; 61(7):1695-1701. PubMed ID: 32186422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin.
    Brunetti L; Di Battista V; Venanzi A; Schiavoni G; Martelli MP; Ascani S; Mecucci C; Tiacci E; Falini B
    Leukemia; 2017 May; 31(5):1238-1240. PubMed ID: 28111467
    [No Abstract]   [Full Text] [Related]  

  • 54. Liposomal Daunorubicin and Cytarabine, a Potential Therapy for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Ashok Kumar P; Ombada M; Pemmasani G; Tambe A; Banki K; Gentile T
    J Investig Med High Impact Case Rep; 2022; 10():23247096221127114. PubMed ID: 36341907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnosis of rare subtypes of acute myeloid leukaemia and related neoplasms.
    George TI; Bajel A
    Pathology; 2021 Apr; 53(3):312-327. PubMed ID: 33676766
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel concepts in plasmacytoid dendritic cell (pDC) development and differentiation.
    Rodrigues PF; Tussiwand R
    Mol Immunol; 2020 Oct; 126():25-30. PubMed ID: 32739721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?
    Osaki Y; Yokohama A; Saito A; Tahara K; Yanagisawa K; Ogawa Y; Ishizaki T; Mitsui T; Koiso H; Takizawa M; Uchiumi H; Saitoh T; Handa H; Murakami H; Tsukamoto N; Nojima Y
    PLoS One; 2013; 8(11):e81722. PubMed ID: 24312342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo and in vitro sensitivity of blastic plasmacytoid dendritic cell neoplasm to SL-401, an interleukin-3 receptor targeted biologic agent.
    Angelot-Delettre F; Roggy A; Frankel AE; Lamarthee B; Seilles E; Biichle S; Royer B; Deconinck E; Rowinsky EK; Brooks C; Bardet V; Benet B; Bennani H; Benseddik Z; Debliquis A; Lusina D; Roussel M; Solly F; Ticchioni M; Saas P; Garnache-Ottou F
    Haematologica; 2015 Feb; 100(2):223-30. PubMed ID: 25381130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathological analysis of 46 cases with CD4
    Suzuki Y; Kato S; Kohno K; Satou A; Eladl AE; Asano N; Kono M; Kato Y; Taniwaki M; Akiyama M; Nakamura S
    Histopathology; 2017 Dec; 71(6):972-984. PubMed ID: 28795410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Case Report: Mature Plasmacytoid Dendritic Cell Proliferation Associated With a Lymphoid Neoplasm.
    Fei F; Liedtke M; Silva O
    Front Oncol; 2022; 12():903113. PubMed ID: 35875095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.